Drug ApprovalsNew kind of blood thinner approved to help prevent repeat strokes
The FDA approved Bayer's asundexian for use with antiplatelet drugs after a recent stroke or high-risk TIA, after it cut ischaemic strokes by 26%. It is not approved for atrial fibrillation.
9 November 2026